Repeated Intake of Grapefruit Juice Inhibits <scp>CYP2B6</scp> , <scp>CYP2C9</scp> , <scp>CYP2C19</scp> , and <scp>CYP3A4</scp> while Lingonberry Powder Does Not Induce Major <scp>CYP</scp> Enzymes in Humans
Year: 2025
Type: article
Language: en
Topic: Pharmacogenetics and Drug Metabolism
Authors and affiliations:
raw_author_name: Laura Aurinsalo
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center Helsinki University Hospital  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Outi Lapatto‐Reiniluoto
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center Helsinki University Hospital  Helsinki Finland
HUS Pharmacy Helsinki University Hospital  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
HUS Pharmacy, Helsinki University Hospital, Helsinki, Finland
raw_author_name: Mika Kurkela
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Mikko Neuvonen
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Eeva Moilanen
raw_affiliation_strings: The Immunopharmacology Research Group, Faculty of Medicine and Health Technology Tampere University, and Tampere University Hospital  Tampere Finland
The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University, and Tampere University Hospital, Tampere, Finland
raw_author_name: Mikko Niemi
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center Helsinki University Hospital  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Aleksi Tornio
raw_affiliation_strings: Integrative Physiology and Pharmacology, Institute of Biomedicine University of Turku  Turku Finland
Unit of Clinical Pharmacology Turku University Hospital  Turku Finland
Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland
Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
raw_author_name: Janne T. Backman
raw_affiliation_strings: Department of Clinical Pharmacology University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center Helsinki University Hospital  Helsinki Finland
Individualized Drug Therapy Research Program, Faculty of Medicine University of Helsinki  Helsinki Finland
Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland